Your session is about to expire
← Back to Search
Monofocal Intraocular Lens
Monofocal IOL Visual Outcomes When Targeting Mini Monovision
N/A
Waitlist Available
Led By Kerry D Solomon
Research Sponsored by Carolina Eyecare Physicians, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a special lens implanted during cataract surgery to improve vision. It targets patients with or without astigmatism and aims to see if focusing both eyes for distance or one eye for near vision works better.
Eligible Conditions
- Presbyopia
- Pseudoaphakia
- Cataract
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mini monovisionExperimental Treatment1 Intervention
The target refraction for the dominant eye will be plano (± 0.25 D) and for the non-dominant eye between -0.75D ±0.15.
Group II: EmmetropiaActive Control1 Intervention
The target refraction for both eyes will be emmetropia (± 0.25 D).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Eyhance IOL
2021
N/A
~280
Find a Location
Who is running the clinical trial?
Carolina Eyecare Physicians, LLCLead Sponsor
10 Previous Clinical Trials
537 Total Patients Enrolled
2 Trials studying Presbyopia
72 Patients Enrolled for Presbyopia
Kerry D SolomonPrincipal InvestigatorCarolina Eyecare Physicians